A 70-year-old ex-smoker with COPD (FEV1 45% predicted) complains of worsening dyspnoea. He uses a short-acting bronchodilator. According to NICE, whic...

Question

A 70-year-old ex-smoker with COPD (FEV1 45% predicted) complains of worsening dyspnoea. He uses a short-acting bronchodilator. According to NICE, which class of medication is next in management?

Accepted Answer

Long-acting muscarinic antagonist (LAMA)

Answer

Inhaled corticosteroid alone

Answer

LABA + inhaled corticosteroid combination

Answer

Oral theophylline

Answer

Roflumilast

ukmla MCQ (SBA): COPD

A 70-year-old ex-smoker with COPD (FEV1 45% predicted) complains of worsening dyspnoea. He uses a short-acting bronchodilator. According to NICE, which class of medication is next in management?